March 2025 Life Sciences Update
08
What Makes an Emerging Market?
CONTENTS
Access to a Healthcare Ecosystem
• Healthcare providers, research institutions and universities help formulate an attractive life sciences market by providing several benefits such as:
Non-Top Tier Hospital
Top Tier Hospital SF
# of Existing Hospitals (RHS)
Collaboration and innovation.
•
40
180
A steady stream of talent.
•
160
35
Improved access to patient populations critical for clinical trials
•
140
30
• Medical professionals have direct access to patients and possess a high level of trust and credibility, which significantly boosts patient enrollment in clinical trials. This helps mitigate low patient participation, which often hinders clinical trials and delays drug development. • According to a report by the SAS Institute, enrollment strategies that leverage healthcare providers and pharmacies were the most effective in recruiting patients. • A strong research and healthcare network in a market enhances innovation and reduces risks of delays in clinical trials.
32%
30%
14%
120
14%
25
100
MSF
20
18%
80
26%
15
11%
60
# of Existing Hospitals
10
40
9%
48%
5
20
0
-
Dallas/Ft. Worth
Houston Hub Avg.
Secondary Avg.
Phoenix
Atlanta Indianapolis Austin Salt Lake City
Source: Cushman & Wakefield Research, Costar
*Hospitals considered top tier are those designated as 4- or 5-star buildings by Costar
41 41
Cushman & Wakefield
Made with FlippingBook - Online magazine maker